Hépato-Gastro & Oncologie Digestive
MENUHepatocellular carcinoma developed in dysmetabolic hepatopathy: Epidemiology and physiopathological mechanisms Volume 29, issue 3, March 2022
Export citation
Citation of this article, in the « Vancouver » format:
Elvire Desjonquères, Jean Charles Nault, Pierre Nahon, Nathalie Ganne, Elia Gigante. Hepatocellular carcinoma developed in dysmetabolic hepatopathy: Epidemiology and physiopathological mechanisms. Hépato-Gastro & Oncologie Digestive. 2022;29(3):353-360. doi:10.1684/hpg.2022.2342